Literature DB >> 25214870

Perivascular epithelioid cell tumor arising in the sacrum: a case report.

Yoon Sung Bae1, Se Hoon Kim1.   

Abstract

Entities:  

Year:  2014        PMID： 25214870      PMCID： PMC4160601          DOI： 10.4132/KoreanJPathol.2014.48.4.331

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN： 1738-1843


× No keyword cloud information.
  10 in total

Review 1.  Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature.

Authors:  Andrew L Folpe; Thomas Mentzel; Hans-Anton Lehr; Cyril Fisher; Bonnie L Balzer; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2005-12       Impact factor: 6.394

2.  A distinctive subset of PEComas harbors TFE3 gene fusions.

Authors:  Pedram Argani; Sebastian Aulmann; Peter B Illei; George J Netto; Jae Ro; Hyun-yee Cho; Snjezana Dogan; Marc Ladanyi; Guido Martignoni; John R Goldblum; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

Review 3.  PEComa presenting in bone: clinicopathologic analysis of 6 cases and literature review.

Authors:  Kyoko Yamashita; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2010-11       Impact factor: 6.394

4.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.

Authors:  T J Hemesath; E Steingrímsson; G McGill; M J Hansen; J Vaught; C A Hodgkinson; H Arnheiter; N G Copeland; N A Jenkins; D E Fisher
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

5.  MUM-1 expression differentiates tumors in the PEComa family from clear cell sarcoma and melanoma.

Authors:  Katalin Ferenczi; Ricardo R Lastra; Tunde Farkas; Rosalie Elenitsas; Xiaowei Xu; Shelley Roberts; John S Brooks; Paul J Zhang
Journal:  Int J Surg Pathol       Date:  2011-09-08       Impact factor: 1.271

Review 6.  PEComa: what do we know so far?

Authors:  J L Hornick; C D M Fletcher
Journal:  Histopathology       Date:  2006-01       Impact factor: 5.087

7.  Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay.

Authors:  Pedram Argani; Priti Lal; Brian Hutchinson; Man Yee Lui; Victor E Reuter; Marc Ladanyi
Journal:  Am J Surg Pathol       Date:  2003-06       Impact factor: 6.394

8.  Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

Authors:  J A Carlson; G R Dickersin; A J Sober; R L Barnhill
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

9.  Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA.

Authors:  Uma Sundram; Jeff D Harvell; Robert V Rouse; Yasodha Natkunam
Journal:  Mod Pathol       Date:  2003-08       Impact factor: 7.842

Review 10.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.